Pulmonary toxicities of molecular targeted antineoplastic agents: a single-center 10-year experience
Min-Young Lee, Seug Yun Yoon, Kyoung Ha Kim, Namsu Lee, Ha Youn Kim, Jung Hwa Hwang, Jong-Ho Won
Korean J Intern Med. 2021;36(3):689-698. Published online 2021 Jan 8 DOI: https://doi.org/10.3904/kjim.2020.295
Citations to this article as recorded by 
Cancer treatments as paradoxical catalysts of tumor awakening in the lung
Emmanuelle Nicolas, Beata Kosmider, Edna Cukierman, Hossein Borghaei, Erica A. Golemis, Lucia Borriello
Cancer and Metastasis Reviews.2024;[Epub] CrossRef
Risk assessment based on dose-responsive and time-responsive genes to build PLS-DA models for exogenously induced lung injury
Lijuan Huang, Zinan Zhang, Huanchun Xing, Yuan Luo, Jun Yang, Xin Sui, Yongan Wang
Ecotoxicology and Environmental Safety.2023; 256: 114891. CrossRef
Bevacizumab/cetuximab
Reactions Weekly.2021; 1868(1): 113. CrossRef
Lung Injury Induced by Antitumor Drugs: Diagnosis, Features of the Clinical Course, Risk Factors, Differential Diagnosis, Treatment, and Prevention. Part 1
N. V. Orlovа, O. D. Ostroumovа, E. V. Shikh, S. V. Smerdin, E. V. Rebrovа, V. А. Dyo
Tuberculosis and Lung Diseases.2021; 99(7): 55. CrossRef
Lung Injury Induced by Antitumor Drugs: Prevalence, Certain Drugs and Their Mechanisms of Action. Part 2
N. V. Orlova, O. D. Ostroumova, E. V. Shikh, S. V. Smerdin, E. V. Rebrova, V. А. Dyo
Tuberculosis and Lung Diseases.2021; 99(8): 54. CrossRef